In Monteiro’s study, cutaneous melanoma accounted for 79% in their cohorts, while acral melanoma consisted of more than 55% of all cases in our study, which mainly attributed to the different CD73 expression rate across studies. The gene discussed is NT5E; the disease is acral lentiginous melanoma.